Patient 4
Adding Optune Gio can help provide long-term clinical outcomes for patients like this one1
Patient 4
61, female
2-year Optune Gio use
- Married
Real patient profile provided by Gautam Prasad, MD, PhD.
Continued treatment with Optune Gio
Optune Gio + adjuvant chemotherapy
- Optune Gio was started after initial chemotherapy and administered concomitantly with maintenance temozolomide for 1 year
- Patient has continued using Optune Gio for an additional year
Side effect management
Chemoradiation therapy
Effects: Mild left temporal alopecia with associated scalp dermatitis; mild nausea
Management: Prescribed antiemetics
Optune Gio
Effects: Intermittent mild dermatitis, particularly over the craniotomy scar
Management: Prescribed topical steroids
Continued treatment with Optune Gio
Optune Gio + adjuvant chemotherapy
- Optune Gio was started after initial chemotherapy and administered concomitantly with maintenance temozolomide for 1 year
- Patient has continued using Optune Gio for an additional year
Side effect management
Chemoradiation therapy
Effects: Mild left temporal alopecia with associated scalp dermatitis; mild nausea
Management: Prescribed antiemetics
Optune Gio
Effects: Intermittent mild dermatitis, particularly over the craniotomy scar
Management: Prescribed topical steroids
Case information used with permission from Gautam Prasad, MD, PhD.
Patient’s MRI
Case information used with permission from Gautam Prasad, MD, PhD.
Patient’s usage report1
Case information used with permission from Gautam Prasad, MD, PhD.
MGMT, O-6-methylguanine-DNA methyltransferase; IDH, isocitrate dehydrogenase; ED, emergency department; WHO, World Health Organization; MRI, magnetic resonance imaging.
Reference: 1. Novocure Data on File OPT-05289.